Seaport Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel neuropsychiatric medicines for high unmet patient needs. Utilizing its proprietary Glyph technology platform, the company overcomes limitations in existing mechanisms to enable oral bioavailability and reduce side effects such as liver toxicity. Led by an experienced team of industry experts, Seaport Therapeutics aims to advance first-in-class therapies through a validated approach.
Open Positions
Senior Director, Clinical Development
5+ years of clinical development experience, MD training in psychiatry/neuroscience, experience with GCP/ICH/FDA requirements
Director, Statistical Programming
10+ years of statistical programming experience in biotech/pharma/CRO settings, with 5+ years of people management experience
Senior Director, Analytical Research & Development
MS or Ph.D. in Analytical Chemistry, Physical Chemistry, or a related scientific discipline, 12–15+ years of progressive industry experience in small‐molecule analytical development, and experience leading analytical development across multiple development stages
Senior/Executive Director, Corporate Counsel
JD from an accredited US law school, 10-15 years of relevant experience, experience in biotech or pharma companies
Clinical Trial Manager
BA/BS degree in Health or Life Sciences, 4+ years of experience, exceptional communication skills